A detailed history of Vista Wealth Management Group, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Vista Wealth Management Group, LLC holds 1,342 shares of VRTX stock, worth $548,555. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,342
Previous 1,313 2.21%
Holding current value
$548,555
Previous $615,000 1.46%
% of portfolio
0.04%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$460.0 - $505.78 $13,340 - $14,667
29 Added 2.21%
1,342 $624,000
Q2 2024

Jul 30, 2024

BUY
$392.81 - $485.53 $14,533 - $17,964
37 Added 2.9%
1,313 $615,000
Q1 2024

Apr 29, 2024

BUY
$407.69 - $446.08 $1,630 - $1,784
4 Added 0.31%
1,276 $533,000
Q4 2023

Feb 12, 2024

BUY
$343.0 - $410.68 $23,324 - $27,926
68 Added 5.65%
1,272 $517,000
Q3 2023

Nov 14, 2023

BUY
$338.18 - $362.46 $407,168 - $436,401
1,204 New
1,204 $418,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Vista Wealth Management Group, LLC Portfolio

Follow Vista Wealth Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vista Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vista Wealth Management Group, LLC with notifications on news.